Related Experiment Video
Updated: Jun 5, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia
1Dementia Research Centre, UCL Institute of Neurology, University College London, Queen Square, London, UK.
Neurology
|December 22, 2010
Summary
Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) subtypes show distinct clinical and neuroimaging patterns. This research highlights the importance of FTLD-TDP subtyping for understanding clinicopathologic correlations in neurodegenerative diseases.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP) is a complex neurodegenerative disease.
- Understanding the distinct clinical and neuroimaging features of FTLD-TDP subtypes is crucial for accurate diagnosis and patient management.
Purpose of the Study:
- To describe the antemortem clinical and neuroimaging characteristics of patients diagnosed with FTLD-TDP.
- To correlate specific FTLD-TDP pathological subtypes with distinct clinical presentations and patterns of brain atrophy.
Main Methods:
- Retrospective review of 28 patients with a neuropathologic diagnosis of FTLD-TDP and antemortem MRI.
- Categorization of patients into FTLD-TDP types 1, 2, and 3 based on pathology, with four patients excluded due to sparse pathology.
- Voxel-based morphometry used to compare regional gray matter atrophy in patients with controls.
Main Results:
- Distinct clinical syndromes were associated with FTLD-TDP subtypes: semantic dementia with type 1, progressive nonfluent aphasia and corticobasal syndrome with type 3, and behavioral variant FTD/FTD-MND with type 2 or 3.
- Neuroimaging revealed specific atrophy patterns: type 1 showed asymmetric anterior temporal lobe atrophy; type 2 displayed symmetric medial temporal and prefrontal atrophy; type 3 exhibited asymmetric atrophy in dorsal frontal, temporal, parietal regions, striatum, and thalamus.
- No significant atrophy was observed in patients with sparse pathology.
Conclusions:
- FTLD-TDP subtypes are characterized by unique clinical and neuroimaging profiles.
- These findings underscore the significance of FTLD-TDP subtyping for establishing clinicopathologic correlations in frontotemporal dementia research.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...